Delivery Order SPE2DB22D2206-SPE2DB24FHW34
- Not listed
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,182.71 firm fixed-price contract is for the supply of medical products including a 0.25% drug solution in 10ml vials. The contract has an ultimate completion date of May 22, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a Firm Fixed Price Delivery Order contract valued at $1,598.40 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract, which has a completion date of June 27, 2024, is for the provision of pharmaceutical products and medical supplies to the DLA. Amerisourcebergen, a major pharmaceutical distribution company, also holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to...
- This contract award is to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order valued at $2,535.32 with a firm fixed price. The contract has no set-aside designation and the ultimate completion date is July 23, 2024. Amerisourcebergen holds several large Indefinite Delivery Contracts (IDCs)...
- This federal contract award, valued at $1,138.70, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order that involves the supply of pharmaceutical products and medical supplies, including items such as syringes, vials, and test kits, to support military treatment programs and facilities worldwide. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
- The contract award, valued at $3,268.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of pharmaceutical products and medical supplies. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract does not have a set-aside designation. Amerisourcebergen, a major supplier of medical products to the federal government, holds a significant Indefinite Delivery Contract (IDC)...
- This is a $6,981.59 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALVEY 40 MG/ML VIALML, a medical product, with a performance period through June 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $16,615.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other government agencies. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
- The U.S. government awarded a Delivery Order contract worth $1,933.32 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, which has a completion date of July 12, 2024, is for the provision of a variety of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract worth $1,653.12 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has a completion date of June 4, 2024, is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA that serves as the primary vehicle for the company to deliver a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHW34Delivery Order
This federal contract award, valued at $2,733.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564977921 TALVEY 3 MG/1.5 ML VIAL 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 6/21/24 |